Close Menu

NEW YORK (GenomeWeb) – Invitae today announced that it is expecting revenues of more than $144 million in 2018, more than double the revenue it generated in 2017.

As part of a preliminary financials report, the company said it doubled testing volume year over year to more than 302,000 samples compared to around 150,000 in 2017. The revenue projections are approximately $2 million above consensus Wall Street estimates, and testing volume exceeds the company's own prior guidance of 285,000 samples.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.